Funding for this research was provided by:
National Natural Science Foundation of China (32422040)
National Natural Science Foundation of China (32301077)
China Postdoctoral Science Foundation (GZC20251531)
China Postdoctoral Science Foundation (2025M782704)
Foundation of Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases (gect-2025-Z01)
Article History
Received: 13 November 2025
Accepted: 22 January 2026
First Online: 30 January 2026
Declarations
:
: All animal procedures were approved by the Laboratory Animal Ethical Committee of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine and conformed to institutional guidelines.
: Not applicable.
: Authors declare that they have no competing interests.